Which myelodysplastic syndrome correlates with 2 cytopenias and 11% blasts in peripheral blood?

Which myelodysplastic syndrome correlates with 2 cytopenias and 11% blasts in peripheral blood?

• A. MDS-EB-2
• B. MDS-SLD
• C. MDS-MLD
• D. MDS-U

Answer: (A)

The condition described involves a myelodysplastic syndrome (MDS) characterized by the presence of two cytopenias and 11% blasts in the peripheral blood. The classification of MDS is determined by the number of cytopenias present and the blast percentage. In the case of MDS, when there are two cytopenias (which can include red blood cells, white blood cells, and platelets being decreased) and the blast percentage is between 5% and 19%, it fits the criteria for MDS with excess of blasts in 2 (MDS-EB-2). This classification specifically indicates that the disease is progressing toward leukemia, evidenced by both the elevated blast count and the presence of cytopenias. Understanding these diagnostic criteria is crucial for effective classification and management of myelodysplastic syndromes. MDS-EB-2 represents a distinct entity that reflects a more advanced stage in the continuum of MDS. In contrast, other potential classifications such as those with single lineage dysplasia (SLD) or minimal dysplasia would not align with the findings of two cytopenias and the specific blast percentage mentioned.

The condition described involves a myelodysplastic syndrome (MDS) characterized by the presence of two cytopenias and 11% blasts in the peripheral blood. The classification of MDS is determined by the number of cytopenias present and the blast percentage.

In the case of MDS, when there are two cytopenias (which can include red blood cells, white blood cells, and platelets being decreased) and the blast percentage is between 5% and 19%, it fits the criteria for MDS with excess of blasts in 2 (MDS-EB-2). This classification specifically indicates that the disease is progressing toward leukemia, evidenced by both the elevated blast count and the presence of cytopenias.

Understanding these diagnostic criteria is crucial for effective classification and management of myelodysplastic syndromes. MDS-EB-2 represents a distinct entity that reflects a more advanced stage in the continuum of MDS. In contrast, other potential classifications such as those with single lineage dysplasia (SLD) or minimal dysplasia would not align with the findings of two cytopenias and the specific blast percentage mentioned.